Trinity Biotech Announces Distribution Agreement for Premier Hb9210 Instrument

Trinity Biotech plc TRIB today announced an agreement to exclusively supply Menarini Diagnostics with the new Premier Hb9210 instrument for distribution in European territories. The Premier Hb9210 instrument is a fully automated system that measures HbA1c in high and low throughput clinical laboratories. HbA1c, also known as glycated hemoglobin, is a measure of a patient's average blood sugar control over the last two to three months